Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 12.958.485.937.805.15

What is the latest EV/Core EBITDA ratio of GLENMARK PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of GLENMARK PHARMACEUTICALS is 12.95 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar202412.95
Mar20238.48
Mar20225.93
Mar20217.80
Mar20205.15

How is EV/Core EBITDA of GLENMARK PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2024 12.95
52.71
Mar2023 8.48
43.00
Mar2022 5.93
-23.97
Mar2021 7.8
51.46
Mar2020 5.15 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹58,050.0 Cr -0.2% -6.1% 39% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹389,172.0 Cr -1.2% -3.6% -8.6% Stock Analytics
DIVIS LABORATORIES ₹158,248.0 Cr -6.6% -12.4% 22.3% Stock Analytics
CIPLA ₹122,835.0 Cr 0.3% 1.2% -5.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,793.0 Cr 0.7% 9.1% 7.2% Stock Analytics
DR REDDYS LABORATORIES ₹101,869.0 Cr 0.4% -2.8% -12.7% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-0.2%

-6.1%

39%

SENSEX

-0.5%

-3.1%

1.4%


You may also like the below Video Courses